Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies
M. Lemaire et al., Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies, VACCINE, 19(32), 2001, pp. 4795-4804
The effects of the vaccination of neonatal calves with a glycoprotein E (gE
)-negative bovine herpesvirus type 1 (BHV-1) were investigated in naive and
passively immunised calves either with the recommended dose or a 5-fold co
ncentrated one. After inoculation (PI), all calves excreted the virus vacci
ne except three passively immunised calves inoculated with the lower titre.
No antibody response could be detected in passively immunised calves, what
ever the dose used, and they all became BHV-1 seronegative and remained so
after dexamethasone treatment (PDT). Nevertheless, as shown by a gamma-inte
rferon assay, all calves that excreted the vaccine PI developed a cell-medi
ated immune response and a booster response was observed PDT, suggesting vi
ral reactivation. The vaccine virus was recovered PDT from nasal secretions
in two calves and BHV-1 DNA were detected in trigeminal ganglia from five
calves belonging to all inoculated groups. The results show that the BHV-1
gE-negative vaccine can establish latency not only in naive but also in pas
sively immunised neonatal calves after a single intranasal inoculation. Mor
eover, this study shows for the first time that the gE-negative vaccine, wh
en used in passively immunised calves, can lead to seronegative vaccine vir
us carriers. (C) 2001 Elsevier Science Ltd. All rights reserved.